Updating results

2778 results

Sort: Relevance | Date

Hormone-sensitive metastatic prostate cancer: docetaxel (ESUOM50)

Summary of the evidence on docetaxel for treating hormone-sensitive metastatic prostate cancer to inform local NHS planning and decision-making

Evidence summary Published January 2016

End-tidal Control software for use with Aisys closed circuit anaesthesia systems for automated gas control during general anaesthesia (MIB10)

Advice on the use of End-tidal Control software with Aisys closed circuit anaesthesia systems for automated gas control during general anaesthesia..

Medtech innovation briefing Published September 2014

The Versajet II hydrosurgery system for surgical debridement of acute and chronic wounds and burns (MIB1)

Advice on the use of the Versajet II hydrosurgery system for surgical debridement of acute and chronic wounds and burns to aid local decision-making

Medtech innovation briefing Published February 2014

Mollii suit for spasticity (MIB100)

Advice on the use of Mollii suit (formerly Elektrodress; a therapeutic electrical stimulation jacket and trousers) for spasticity to aid local decision-making

Medtech innovation briefing Published March 2017

Zio Service for detecting cardiac arrhythmias (MIB101)

Advice on the use of the Zio Service (a remote cardiac monitoring system) for detecting cardiac arrhythmias to aid local decision-making

Medtech innovation briefing Published March 2017

Aptiva for painful diabetic neuropathy (MIB119)

Advice on the use of Aptiva for painful diabetic neuropathy to aid local decision-making

Medtech innovation briefing Published September 2017

The NxStage System One NX1000‑1 home haemodialysis device for renal replacement therapy in chronic kidney disease (MIB12)

Advice on the use of the NxStage System One NX1000-1 home haemodialysis device for renal replacement therapy in chronic kidney disease (CKD)..

Medtech innovation briefing Published November 2014

Caris Molecular Intelligence for guiding cancer treatment (MIB120)

Advice on the use of Caris Molecular Intelligence (CMI; solid tumour biomarker analysis service) for guiding cancer treatment to aid local decision-making

Medtech innovation briefing Published September 2017

Farco-fill Protect for indwelling urinary catheterisation (MIB121)

Advice on the use of Farco-fill Protect for inflating Foley catheter balloons for indwelling (in-situ) urinary catheterisation to aid local decision-making

Medtech innovation briefing Published September 2017

Neo Pedicle Screw System for spinal fusion surgery (MIB108)

Advice on the use of Neo Pedicle Screw System (single-use instruments, implantable screws and rods) for spinal fusion surgery to aid local decision-making

Medtech innovation briefing Published June 2017

RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (MIB109)

Advice on the use of RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (IBD) to aid local decision-making

Medtech innovation briefing Published June 2017

Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds (MIB11)

Advice on the use of Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds to aid local decision-making

Medtech innovation briefing Published November 2014

VAAFT for treating anal fistulae (MIB102)

Advice on the use of VAAFT for treating anal fistulae to aid local decision-making

Medtech innovation briefing Published April 2017

Hemosep for cell salvage (MIB103)

MIB103 No intro Summary The technology described in this briefing is Hemosep. It is used for cell salvage and

Medtech innovation briefing Published May 2017

NaviCam for diagnosing gastrointestinal tract conditions (MIB104)

Advice on the use of NaviCam for diagnosing gastrointestinal (GI) tract and small bowel conditions to aid local decision-making

Medtech innovation briefing Published May 2017

Permacol for treating anal fistulae (MIB105)

Advice on the use of Permacol for treating anal fistulae (fistula) to aid local decision-making

Medtech innovation briefing Published May 2017

Bindex for investigating suspected osteoporosis (MIB106)

Advice on the use of Bindex (portable pulse echo ultrasound device) for investigating suspected osteoporosis to aid local decision-making

Medtech innovation briefing Published May 2017

SecurAcath for securing cerebrospinal fluid catheters (MIB107)

Advice on the use of SecurAcath for securing cerbrospinal fluid (CSF) drainage catheters to aid local decision-making

Medtech innovation briefing Published June 2017

FebriDx for C-reactive protein and Myxovirus resistance protein A testing in primary care (MIB114)

Advice on the use of FebriDx for C-reactive protein and Myxovirus resistance protein A testing in primary care to aid local decision-making

Medtech innovation briefing Published July 2017

VEST external stent for coronary artery bypass grafts (MIB115)

Advice on the use of VEST external stent for coronary artery bypass grafts to aid local decision-making

Medtech innovation briefing Published August 2017

Urethrotech UCD for difficult or failed catheterisation (MIB116)

Advice on the use of Urethrotech urethral catheterisation device (UCD) for difficult or failed catheterisations in men to aid local decision-making

Medtech innovation briefing Published August 2017

Biopatch for venous or arterial catheter sites (MIB117)

Advice on the use of Biopatch hydrophilic foam dressing with chlorhexidine gluconate (CHG) for venous or arterial catheter sites to aid local decision-making

Medtech innovation briefing Published August 2017

FreeStyle Libre for glucose monitoring (MIB110)

Advice on the use of FreeStyle Libre for monitoring glucose levels in diabetes to aid local decision-making

Medtech innovation briefing Published July 2017 Last updated September 2017

L-Dex U400 for lymphoedema after breast cancer treatment (MIB111)

Advice on the use of L-Dex U400 for lymphoedema (lymphedema) after breast cancer treatment to aid local decision-making

Medtech innovation briefing Published July 2017

Arctic Sun 5000 for therapeutic hypothermia after cardiac arrest (MIB112)

Advice on the use of Arctic Sun 5000 for therapeutic hypothermia after cardiac arrest to aid local decision-making

Medtech innovation briefing Published July 2017

Nasal Alar SpO2 sensor for monitoring oxygen saturation by pulse oximetry (MIB113)

Advice on the use of the Nasal Alar SpO2 sensor for monitoring oxygen saturation by pulse oximetry to aid local-decision making

Medtech innovation briefing Published July 2017

Thora-3Di for assessing asthma in children (MIB122)

Advice on the use of Thora-3Di for assessing asthma in children (paediatric) to aid local decision-making

Medtech innovation briefing Published October 2017

Memokath-028, 044 and 045 stents for urethral obstruction (MIB123)

Advice on the use of Memokath-028, 044 and 045 stents for urethral obstruction and bladder neck or outlet obstructions in men to aid local decision-making

Medtech innovation briefing Published October 2017

PleuraFlow Active Clearance Technology for maintaining chest tube patency (MIB125)

Advice on the use of PleuraFlow Active Clearance Technology (ACT) for maintaining chest tube patency to aid local decision-making

Medtech innovation briefing Published October 2017

Radiation dose monitoring software for medical imaging with ionising radiation (MIB127)

Advice on the use of radiation dose monitoring software for medical imaging with ionising radiation to aid local decision-making

Medtech innovation briefing Published October 2017

HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer (MIB128)

Advice on the use of HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer (NSCLC) to aid local decision-making

Medtech innovation briefing Published November 2017

Health app: Sleepio for adults with poor sleep (MIB129)

Advice on the use of the Sleepio health app to help adults with poor sleep improve sleep through cognitive behavioural therapy, to aid local decision-making

Medtech innovation briefing Published November 2017

Induction of labour in late intrauterine fetal death: vaginal misoprostol (after oral mifepristone) (ESUOM11)

Summary of the evidence on vaginal misoprostol (after oral mifepristone) for induction labour in late intrauterine fetal death (IUFD)..

Evidence summary Published April 2013

Generalised anxiety disorder: quetiapine (ESUOM12)

Summary of the evidence on quetiapine monotherapy for treating generalised anxiety disorder (GAD) to inform local NHS planning and decision-making

Evidence summary Published May 2013

Gastroparesis in adults: oral erythromycin (ESUOM13)

Summary of the evidence on oral erythromycin for gastroparesis (delayed stomach emptying) in adults to inform local NHS planning and decision-making

Evidence summary Published June 2013

Chronic anal fissure: botulinum toxin type A injection (ESUOM14)

Summary of the evidence on botulinum toxin type A injection for treating chronic anal fissure to inform local NHS planning and decision-making

Evidence summary Published June 2013

Hypersalivation: oral glycopyrronium bromide (ESUOM15)

Summary of the evidence on oral glycopyrronium bromide for treating hypersalivation (sialorrhoea) to inform local NHS planning and decision-making

Evidence summary Published July 2013

Hyperhidrosis: oral glycopyrronium bromide (ESUOM16)

Summary of the evidence on oral glycopyrronium bromide for treating hyperhidrosis (excessive sweating) to inform local NHS planning and decision-making

Evidence summary Published July 2013

Promoting tolerance of enteral feeds in children and young people: domperidone (ESUOM18)

Summary of the evidence on domperidone to promote tolerance of enteral feeds in children and young people..

Evidence summary Published July 2013 Last updated September 2014

Reversal of the anticoagulant effect of dabigatran: idarucizumab (ESNM73)

Summary of the evidence on idarucizumab for reversing the anticoagulant effect of dabigtatran to inform local NHS planning and decision-making

Evidence summary Published May 2016

Complicated urinary tract infections: ceftolozane/tazobactam (ESNM74)

Summary of the evidence on ceftolozane/tazobactam for treating complicated urinary tract infections to inform local NHS planning and decision-making

Evidence summary Published June 2016

Complicated intra-abdominal infections: ceftolozane/tazobactam (ESNM75)

Summary of the evidence on ceftolozane/tazobactam for treating complicated intra-abdominal infections to inform local NHS planning and decision-making

Evidence summary Published June 2016

Interstitial cystitis: dimethyl sulfoxide bladder instillation (ESUOM26)

Summary of the evidence on dimethyl sulfoxide bladder instillation for treating interstitial cystitis to inform local NHS planning and decision-making

Evidence summary Published February 2014

Chronic pain: oral ketamine (ESUOM27)

Summary of the evidence on oral ketamine for treating chronic pain to inform local NHS planning and decision-making

Evidence summary Published February 2014 Last updated June 2014

Difficult-to-treat scabies: oral ivermectin (ESUOM29)

Summary of the evidence on oral ivermectin for treating difficult-to-treat scabies to inform local NHS planning and decision-making

Evidence summary Published March 2014

Migraine prophylaxis: flunarizine (ESUOM33)

Summary of the evidence on flunarizine for treating migraine prophylaxis to inform local NHS planning and decision-making

Evidence summary Published September 2014

Management of vomiting in children and young people with gastroenteritis: ondansetron (ESUOM34)

Summary of the evidence on ondansetron for the management of vomiting in children and young people with acute gastroenteritis...

Evidence summary Published October 2014

Immune (idiopathic) thrombocytopenic purpura: rituximab (ESUOM35)

Summary of the evidence on rituximab for immune (idiopathic) thrombocytopenic purpura in adults to inform local NHS planning and decision-making

Evidence summary Published October 2014

Systemic lupus erythematosus: oral mycophenolate (ESUOM36)

Summary of the evidence on oral mycophenolate for systemic lupus erythematosus (SLE) to inform local NHS planning and decision-making

Evidence summary Published November 2014

Chronic anal fissure: 2% topical diltiazem hydrochloride (ESUOM3)

Summary of the evidence on 2% topical diltiazem hydrochloride for chronic anal fissure to inform local NHS planning and decision-making

Evidence summary Published January 2013